GSA Capital Partners LLP Buys Shares of 119,578 Paysign, Inc. $PAYS
GSA Capital Partners LLP has acquired a new stake of 119,578 shares in Paysign, Inc. (NASDAQ:PAYS) during the second quarter, valued at approximately $979,000. This makes GSA Capital Partners LLP an owner of 0.21% of Paysign's stock. Other institutional investors also increased their holdings, and the article details recent financial performance, analyst ratings, and insider trading activities for Paysign.
Paysign, Inc. to Present at the 17th Annual Midwest IDEAS Investor Conference
Paysign, Inc. announced its participation in the 17th Annual Midwest IDEAS Investor Conference, scheduled for August 26-27, 2026, in Chicago. Key executives, including CEO Mark Newcomer, CFO Jeff Baker, and Matt Turner, will attend to engage with institutional investors in one-on-one and group meetings. The conference provides a platform for quality public companies to connect with top investment professionals.
107,077 Shares in Paysign, Inc. $PAYS Acquired by OneDigital Investment Advisors LLC
OneDigital Investment Advisors LLC recently acquired 107,077 shares of Paysign, Inc. ($PAYS) valued at approximately $877,000, bringing institutional ownership to 25.89%. Despite recent insider stock sales by the CEO and CFO, the company reported strong Q2 earnings, exceeding analyst estimates, and analysts maintain a consensus "Buy" rating with an average price target of $13.33. Paysign, a financial technology company specializing in prepaid payment solutions, also issued positive fiscal 2026 EPS guidance.
Paysign CEO Mark Newcomer sells $1.78m in common stock
Paysign CEO Mark Newcomer sold 150,000 shares of the company's common stock for $1.78 million, executing the sale under a Rule 10b5-1 trading plan. This transaction occurred as Paysign's shares were trading near their 52-week high after a significant 289% surge in six months. The company recently reported strong Q2 2026 earnings, exceeding analyst expectations and raising its full-year outlook.
Paysign (NASDAQ:PAYS) Stock Rating Lowered by Wall Street Zen
Wall Street Zen has downgraded Paysign (NASDAQ:PAYS) from "strong-buy" to "buy," although the broader analyst consensus remains "Buy" with an average price target of $13.33. The company recently reported strong quarterly earnings, exceeding both EPS and revenue estimates, and issued positive fiscal 2026 EPS guidance. Despite these positive financial results, there have been significant insider stock sales totaling over $4 million in the past 90 days.
PaySign Inc (PAYS) CFO Jeffery Baker Sells 35,000 Shares
PaySign Inc's CFO, Jeffery Baker, sold 35,000 shares of PAYS on August 12, 2026, for approximately $441,700. This sale contributes to a broader trend of insider selling with no corresponding buying over the past year, suggesting that insiders might view the stock as overvalued. GuruFocus analysis supports this, indicating the stock is significantly overvalued with a price-to-GF-Value ratio of 1.93 and a high P/E ratio compared to its industry median.
Insider Selling: Paysign (NASDAQ:PAYS) CFO Sells $441,700.00 in Stock
Paysign (NASDAQ:PAYS) CFO Jeffery Bradford Baker sold 35,000 shares of the company's stock for $441,700.00. This transaction reduced his holdings by 6.06% to 542,171 shares. The sale occurred shortly after Paysign exceeded quarterly earnings expectations and provided positive fiscal 2026 guidance, with shares trading near their 52-week high.
Paysign (PAYS) CFO Baker sells 35,000 shares at $12.62 weighted average
Paysign, Inc.'s Chief Financial Officer, Jeffery Bradford Baker, reported selling 35,000 shares of common stock on August 12, 2026. The shares were sold at a weighted average price of $12.6182, with individual trades ranging from $12.54 to $12.72. Following this transaction, Baker directly holds 542,171 shares of Paysign common stock.
Pretax income of Paysign, Inc. – DUS:2ZE
This page displays financial information for Paysign, Inc. (DUS:2ZE) on the Dusseldorf Stock Exchange, specifically focusing on its pretax income. The article provides a high-level overview of the company's financials without specific figures. It also lists various features and services offered by TradingView.
Paysign, Inc. $PAYS Shares Acquired by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP increased its stake in Paysign, Inc. (NASDAQ:PAYS) by 16.8% in the first quarter, acquiring 82,736 shares to hold a total of 575,619 shares. This comes amidst insider selling by Director Bruce A. Mina and EVP Joan M. Herman, though company insiders still retain a significant ownership stake. Analysts maintain a "Buy" rating for Paysign, with a consensus price target of $13.33, following the company's recent earnings beat.
PaySign Inc (PAYS) CEO and 10% Owner Mark Newcomer Sells 150,000 Shares
PaySign Inc CEO and 10% owner Mark Newcomer sold 150,000 shares of PAYS on August 6, 2026, for approximately $1.78 million, bringing his total ownership to 9,163,002 shares. This sale is part of a broader trend of insider selling at PaySign, with no insider buys in the past year and 9 insider sells, while the stock is considered significantly overvalued according to GuruFocus's GF Value of $6.40 compared to its trading price of $11.88.
CEO stock sale: Paysign, Inc. (PAYS) chief sells 150,000 shares
Paysign, Inc.'s CEO, Mark Newcomer, sold 150,000 shares of common stock on August 6, 2026, at a weighted average price of $11.8757 per share. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan established in September 2025. Following the sale, Newcomer still directly holds over 9.1 million shares of the company.
Total debt per share of Paysign, Inc. – FWB:2ZE
This article provides the title "Total debt per share of Paysign, Inc. – FWB:2ZE" and indicates that the market is closed with no trades. It is a financial data page from TradingView for Paysign, Inc. on the Frankfurt Stock Exchange.
Paysign (PAYS) director converts 20,000-share grant, now holds 290,000
Paysign, Inc. director Dennis L. Triplett converted a 20,000-share stock grant into common stock on August 4, 2026. This transaction increased his direct holdings to 290,000 shares of Paysign common stock, following the vesting of the grant which was originally received on August 4, 2025. The conversion was made at $0.0000 per share and was not executed under a Rule 10b5-1 trading plan.
Paysign, Inc. (PAYS) director exercises 20,000-share grant, now holds 90,000
Paysign, Inc. director Jeffrey B. Newman exercised a stock grant of 20,000 derivative shares, converting them into 20,000 shares of common stock on August 4, 2026. The grant, awarded on August 4, 2025, fully vested by the filing date. Following this transaction, Newman directly owns 90,000 shares of Paysign common stock.
Paysign, Inc. (PAYS) director converts 20,000-share grant into stock
Paysign, Inc. director Henry Daniel R converted a 20,000-share stock grant into common stock on August 4, 2026, increasing his direct holdings to 169,884.498 shares. The grant, originally received on August 4, 2025, vested on August 4, 2026, with the transaction occurring at $0.00 per share. This insider transaction, identified by transaction code M, was not part of a Rule 10b5-1 trading plan.
Paysign (PAYS) director adds 20,000 vested shares, holdings reach 278,500
Paysign, Inc. director Bruce A. Mina acquired 20,000 shares of common stock through the vesting and conversion of a prior stock grant on August 04, 2026. This transaction increased his direct holdings of Paysign common stock to 278,500 shares. The original grant was made on August 04, 2025, and has now fully vested.
Paysign, Inc. 2026: Revenue $28.25M, EPS $0.11— 10-Q Summary
Paysign, Inc. (PAYS) reported strong financial results for the 2026 period, with revenue reaching $28.25 million and diluted EPS at $0.11. This significant year-over-year growth was driven by a 48.1% increase in total revenue, alongside a substantial rise in net income and diluted EPS. The company's performance was bolstered by expanded pharma and plasma program volumes, leading to investments in operational scaling.
Paysign, Inc. Stock 12‑Month Price Target Raised to $11.05, Implies 15% Upside
Paysign, Inc.'s average stock price target has been raised from $10.45 to $11.9 by five analysts, implying a 24% potential upside from its August 5th closing price. The consensus rating remains a "Buy" from all five covering analysts. This update suggests a strong positive outlook for the company's stock performance.
Paysign (NASDAQ:PAYS) Flashes Minervini-Style Momentum With Strong Uptrend and Accelerating Fundamentals
Paysign (NASDAQ:PAYS) exhibits strong Minervini-style momentum, characterized by a robust technical uptrend and accelerating fundamentals. The company meets the rigorous Trend Template criteria, showing significant price appreciation and rising moving averages, alongside impressive earnings and revenue growth. This combination suggests PAYS is a market leader with high relative strength and improving profitability, though investors should consider risk management for potential entry points.
Paysign, Inc. Stock 12‑Month Price Target Raised to $11.05, Implies 15% Upside
The average price target for Paysign, Inc. (PAYS) stock has increased from $10.45 to $11.9, according to estimates from 5 analysts. This updated target implies approximately a 24% potential upside based on the August 5 closing price. The consensus rating for PAYS remains a "Buy" from all 5 covering analysts.
PaySign Inc (PAYS) (Q2 2026) Earnings Call Highlights: Record Revenue Surges 48% as Patient ...
PaySign Inc (PAYS) reported record Q2 2026 results with total revenue surging 48.1% to $28.3 million, driven significantly by an 88.9% increase in Pharma Revenue. Net income nearly quintupled to $6.8 million, and adjusted EBITDA more than doubled to $9.6 million. The company also raised its full-year 2026 guidance, expecting continued strong growth in revenue and adjusted EBITDA, primarily due to the robust performance of its Patient Affordability segment and a healthy pipeline of new programs.
Paysign Q2 2026 Earnings: Pharma Growth Drives 48% Revenue Increase
Paysign (NASDAQ: PAYS) reported a 48.1% year-over-year revenue increase to $28.25 million in Q2 2026, driven primarily by growth in pharma patient affordability programs. This shift towards higher-margin pharma revenue also led to significant margin expansion, with GAAP diluted EPS rising to $0.11 from $0.02. The company raised its full-year 2026 revenue outlook to $114 million-$117 million and adjusted EBITDA outlook to $35 million-$38 million.
PAYS: Record revenue, margin expansion, and raised outlook driven by Patient Affordability growth
Paysign, Inc. (PAYS) reported record Q2 results, with 48% revenue growth and a 113% increase in adjusted EBITDA, primarily due to Patient Affordability and plasma recovery. The company raised its full-year guidance, expanded margins, and demonstrated platform scalability. This positive performance was highlighted during their Q2 2026 earnings call on August 5, 2026.
PaySign Inc (PAYS) (Q2 2026) Earnings Call Highlights: Record Revenue Surges 48% as Patient ...
PaySign Inc (PAYS) reported record second-quarter 2026 results, with total revenue surging 48.1% year-over-year to $28.3 million, driven primarily by an 88.9% increase in Pharma Revenue to $14.6 million. Net income saw a nearly five-fold increase to $6.8 million, and adjusted EBITDA rose by 113% to $9.6 million. The company raised its full-year 2026 guidance, expecting continued strong growth, but faces potential risks related to concentration in the patient affordability segment, delays in FDA approval for its Apherion BECS system, and rising operating expenses.
Earnings call transcript: Paysign tops Q2 2026 estimates and lifts outlook
Paysign Inc. reported strong second-quarter 2026 results, surpassing Wall Street's earnings and revenue estimates and leading to a raised full-year outlook. The company's performance was significantly driven by its patient affordability programs, which saw an 89% increase in revenue, and a recovery in its plasma business. Paysign's stock reacted positively, nearing its 52-week high, as management expressed confidence in continued growth and expanding margins.
Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook
Paysign, Inc. reported record second-quarter 2026 revenue of $28.3 million, a 48% increase year-over-year, driven by significant growth in its pharma patient affordability business (up 88.9%) and steady performance in plasma revenue (up 21.4%). The company also saw its GAAP net income increase by 386.9% to $6.76 million and raised its full-year 2026 revenue outlook to $114.0 million to $117.0 million and Adjusted EBITDA to $35.0 million to $38.0 million. These results reflect strong operating leverage, margin expansion, and successful execution of its multiyear strategy.
Paysign, Inc. (NASDAQ: PAYS) raises 2026 outlook after 48% Q2 revenue growth
Paysign, Inc. reported a record Q2 2026 revenue of $28.25 million, marking a 48.1% increase year-over-year, driven by substantial growth in its pharma and plasma segments. The company also saw significant profitability improvements, with GAAP net income reaching $6.76 million and Adjusted EBITDA more than doubling to $9.61 million. Based on this strong performance, management has raised its full-year 2026 guidance for both revenue and Adjusted EBITDA.
Paysign, Inc. (PAYS) officer reports 64,000-share vesting and tax withholding
Paysign, Inc.'s Chief Payments Officer, Matthew Louis Lanford, reported the vesting of 64,000 restricted shares into common stock on July 31, 2026. Concurrently, 25,185 shares were withheld at $8.96 per share to cover tax obligations. This vesting is part of an award granted in 2022, with shares vesting in equal annual installments until July 31, 2027.
Paysign (PAYS) CLO details 64,000-share vesting and tax withholding
Paysign, Inc.'s Chief Legal Officer, Robert Strobo, reported the vesting of 64,000 restricted stock shares and their conversion into common stock on July 31, 2026. To cover tax obligations, 25,184 shares were withheld by the issuer at $8.96 per share. This vesting is part of a five-year annual installment plan that began on July 31, 2022, and will be fully vested by July 31, 2027.
Paysign (PAYS) CFO exercises stock grant; 28,506 shares withheld for taxes
Paysign, Inc.'s Chief Financial Officer, Jeffery Bradford Baker, exercised a stock grant of 64,000 shares on July 31, 2026. This exercise involved the vesting of restricted stock, with 28,506 shares withheld by the company at $8.96 per share to cover tax obligations. After the transaction, Baker's direct holdings include 64,000 shares from the stock grant and 577,171 shares of common stock.
Earnings To Watch: PaySign Inc (PAYS) Q2 2026 -- GF Value Sees 21% Downside
PaySign Inc (PAYS) is scheduled to release its Q2 2026 earnings on August 5, 2026, with revenue and earnings estimates showing slight increases for 2026 and 2027. Despite beating analysts' expectations in the previous quarter, the stock saw a 12.33% decline. While analysts' average price target suggests a 13.22% upside, GuruFocus's GF Value indicates a potential 21.45% downside.
Paysign (NASDAQ:PAYS) Sets New 52-Week High - Should You Buy?
Paysign (NASDAQ:PAYS) recently achieved a new 52-week high of $9.49, supported by positive analyst sentiment, with a consensus "Buy" rating and a target price of $10.33. The company surpassed its Q1 2026 earnings expectations, reporting $0.09 EPS on revenues of $28.04 million. Despite strong performance, insiders have sold 221,736 shares worth approximately $1.8 million in the last three months, which is a factor for potential investors to consider.
Earnings To Watch: PaySign Inc (PAYS) Q2 2026 -- GF Value Sees 21% Downside
PaySign Inc (PAYS) is scheduled to release its Q2 2026 earnings on August 5, 2026, with revenue expected at $26.35 million and EPS at $0.06. While analysts forecast an average target price of $10.45, implying a 13.22% upside, GuruFocus estimates a GF Value of $7.25, suggesting a 21.45% downside from the current price of $9.23. The company previously beat Q1 2026 revenue and earnings expectations, though its stock dipped post-announcement.
Renaissance Technologies LLC Grows Stake in Paysign, Inc. $PAYS
Renaissance Technologies LLC increased its stake in Paysign, Inc. by 17.4% in the first quarter of 2026, bringing its total holdings to 1.53 million shares valued at $9.0 million. This move is supported by a generally positive analyst outlook, with a consensus "Buy" rating and a target price of $10.00. Despite significant insider selling totaling $1.8 million, Paysign's Q1 results exceeded analyst expectations with EPS of $0.09 and revenue of $28.04 million.
Form 4 Paysign Inc For: 31 July By Investing.com
This article announces the filing of a Form 4 for Paysign Inc., dated July 31. It is a brief report from Investing.com, likely detailing insider transactions for the company. The content includes market data for various indices, commodities, bonds, and shares.
Paysign (PAYS) director receives 20,000-share stock grant vesting 2027
Paysign, Inc. director Jeffrey B. Newman received a grant of 20,000 common shares on May 8, 2026. These shares will vest on May 8, 2027, bringing his total direct holdings to 70,000 Paysign common shares. The grant was reported in a Form 4 filing and the shares were awarded at a price of $0.00 per share.
Paysign (NASDAQ:PAYS) Director Sells $70,900.00 in Stock
Paysign (NASDAQ:PAYS) Director Bruce Mina sold 10,000 shares of the company's stock for $70,900 on June 11th, reducing his ownership by 3.72%. Despite the sale, Paysign exceeded first-quarter earnings and revenue expectations, and analysts maintain a consensus "Buy" rating with an average price target of $10.00. The stock recently traded down 2.2% at $8.96, close to its 12-month high.
Paysign (NASDAQ:PAYS) Director Bruce Mina Sells 10,000 Shares
Paysign Director Bruce Mina sold 10,000 shares of the company's stock for $71,000, reducing his direct ownership by 3.59%. This transaction follows Paysign's recent earnings beat and occurs while the stock trades near its 12-month high. Analysts generally maintain a "Buy" rating for PAYS, with institutional investors holding a significant portion of the company.
Insider Selling: Paysign (NASDAQ:PAYS) CEO Sells $469,000.00 in Stock
Paysign CEO Mark Newcomer sold 50,000 shares of the company's stock for $469,000 under a pre-arranged trading plan, reducing his stake by 0.54%. Despite the insider selling, Paysign's stock traded near its 52-week high, and the company exceeded recent earnings and revenue expectations. Analysts maintain a "Buy" rating for PAYS with an average price target of $10.00.
Paysign CEO Mark Newcomer sells $468,985 in stock
Paysign Inc. CEO Mark Newcomer sold 50,000 shares of the company's common stock for $468,985 on July 29, 2026, as part of a pre-arranged trading plan. Despite the sale, Newcomer still holds over 9.2 million shares. The company recently reported strong first-quarter 2026 results, exceeding earnings and revenue forecasts, which led to DA Davidson reiterating a Buy rating.
Director at Paysign, Inc. (PAYS) receives 20,000-share stock grant
Paysign, Inc. (PAYS) director Henry Daniel R received a grant of 20,000 shares of common stock on May 8, 2026, which will vest on May 8, 2027. Following this grant, his direct ownership in Paysign totals 149,884.198 shares. This transaction was reported in a Form 4 filing and was not made under a Rule 10b5-1 plan.
Paysign, Inc. (PAYS) director reports 20,000-share grant and two stock sales
Paysign, Inc. director Bruce A. Mina reported receiving a grant of 20,000 shares of common stock on May 8, 2026, vesting on May 8, 2027. Subsequently, he sold 10,000 shares on June 1, 2026, at $7.10 per share and another 10,000 shares on June 11, 2026, at $7.095 per share. These transactions were not conducted under a Rule 10b5-1 trading plan.
Paysign CEO Mark Newcomer sells $468,985 in stock
Paysign Inc.'s CEO, Mark Newcomer, sold 50,000 shares of company stock for $468,985 on July 29, 2026. This sale occurred while the stock had surged 115% over the past six months, despite trading currently below the sale price. The company recently reported strong first-quarter 2026 results, exceeding EPS and revenue forecasts, leading DA Davidson to reiterate a Buy rating.
Paysign director Bruce Mina sells $141,950 in company stock
Paysign director Bruce Mina sold $141,950 worth of company stock in June 2026 through two transactions. Despite these sales, the company's shares have since climbed over 26%, and Mina still beneficially owns 258,500 shares. The sales occurred after Mina received a grant of 20,000 shares in May 2026, and Paysign recently reported strong Q1 2026 results, exceeding earnings and revenue forecasts.
Paysign, Inc. (PAYS) CEO sells 50,000 shares in 10b5-1 plan
Paysign, Inc. CEO Mark Newcomer sold 50,000 shares of common stock on July 29, 2026, at a weighted average price of $9.3797 per share, totaling approximately $469,000. This sale was conducted under a Rule 10b5-1 trading plan established on September 12, 2025. Following the transaction, Newcomer directly holds 9,222,027 shares of Paysign Common Stock.
Paysign Inc (PAYS) Risk Assessment: Volatility, Financial Risk & Investment Risk
Paysign Inc (PAYS) has a current risk assessment score of 4.95, ranking 93 out of 160 in the Professional & Commercial Services industry. The company's beta of 0.73 indicates it tends to underperform in up markets but decline less in down markets. Key risk metrics include a 240-day maximum drawdown of +49.84% and volatility of +63.62%, with a 5-year Sharpe Ratio of +0.74.
Paysign Inc (PAYS) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis for Paysign Inc (PAYS), noting its current valuation score of 7.19, ranking 124 out of 160 in its industry. It highlights the company's P/E ratio of 48.24, which is significantly below its recent high but above its recent low. The report also indicates that relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.
PAYS|Paysign Inc|Price:9.110|Chg%:+0.220
This article provides a comprehensive stock analysis of Paysign Inc (PAYS) using the TradingKey Stock Score. It highlights Paysign's healthy fundamentals, high growth potential, and fair valuation within the Professional & Commercial Services industry. The analysis also covers institutional ownership, analyst ratings, and various risk and momentum indicators, suggesting a potential for upward trend in the medium term.
Paysign Inc (PAYS) Cash Flow
This article provides a detailed quarterly and annual cash flow statement for Paysign Inc (PAYS), allowing users to evaluate the company's financial soundness and stability. It breaks down operating, investing, and financing cash flows, including net income, capital expenditures, and changes in working capital. The data is presented with year-over-year percentage changes and absolute figures for various financial metrics.
